How has been the historical performance of Maris Spinners?

Oct 08 2025 10:38 PM IST
share
Share Via
Maris Spinners has experienced fluctuating financial performance, with net sales increasing to 169.01 Cr in Mar'25 but profitability remaining a challenge, as reflected in a loss of -1.26 Cr after tax. While there are signs of recovery in sales and cash flow, the company continues to face issues with profitability and financial health.
Answer:
The historical performance of Maris Spinners shows fluctuations in key financial metrics over the years, with a notable decline in profitability in recent periods.

Breakdown:
Maris Spinners reported net sales of 169.01 Cr in Mar'25, an increase from 160.65 Cr in Mar'24 and 146.80 Cr in Mar'23, although it is lower than the 170.40 Cr recorded in Mar'22. The total operating income followed a similar trend, reaching 169.01 Cr in Mar'25, up from 160.65 Cr in Mar'24 but down from 171.97 Cr in Mar'22. The company faced challenges with raw material costs, which increased to 115.20 Cr in Mar'25 from 108.53 Cr in Mar'24, while total expenditure decreased slightly to 163.83 Cr in Mar'25 from 165.54 Cr in Mar'24. Operating profit, excluding other income, was 5.18 Cr in Mar'25, a recovery from -4.89 Cr in Mar'24, but significantly lower than the 31.09 Cr in Mar'22. Profit before tax improved to -1.65 Cr in Mar'25 from -13.27 Cr in Mar'24, while profit after tax also showed a slight recovery to -1.26 Cr from -9.13 Cr. The earnings per share (EPS) reflected this trend, with a loss of -1.59 in Mar'25 compared to -11.53 in Mar'24. On the balance sheet, total liabilities decreased to 122.21 Cr in Mar'25 from 126.28 Cr in Mar'24, while total assets also declined to 122.21 Cr from 126.28 Cr. The cash flow from operating activities improved to 14.00 Cr in Mar'25 from 4.00 Cr in Mar'24, indicating a positive shift in operational cash generation. Overall, while Maris Spinners has shown some signs of recovery in sales and cash flow, it continues to struggle with profitability and overall financial health.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News